You're Avoiding Perfume, Yet Still React. Here's Why.

GSTM1 is one of your body’s primary detoxification enzymes. Its job is to grab onto fragrance chemicals and other environmental toxins, attach glutathione (a protective molecule) to them, and mark them for elimination. It’s like putting a shipping label on a package so your body knows to send it out.

Here’s the problem: roughly 50% of the population carries a deletion of the entire GSTM1 gene. If you’re in that group, you don’t produce this enzyme at all. Without GSTM1, a major pathway for eliminating fragrance chemicals simply doesn’t exist. Your body has to rely on other, less efficient detox routes.

For people without functional GSTM1, even moderate fragrance exposure leads to accumulation. A person without this gene walking into a store with heavy fragrance in the air is, biochemically speaking, unable to process what they’re inhaling. The chemicals accumulate in tissues, setting off oxidative stress and inflammation. You feel it as a headache or respiratory irritation within minutes.

GSTP1 is another critical phase II enzyme, and it works in tissues throughout your body, not just your liver. It’s especially active in your lungs and respiratory epithelium, the tissues that first encounter inhaled fragrance molecules. Its job is to conjugate those fragrance chemicals and prevent them from causing oxidative damage to your cells.

The Ile105Val variant (the Val allele) is carried by roughly 35-40% of the population. People with this variant produce a less efficient version of the GSTP1 enzyme. This reduced activity means fragrance chemicals linger longer in your respiratory tissues before they’re neutralized. Your lung cells experience prolonged exposure to reactive fragrance molecules, triggering inflammation and irritation.

If you have this variant, your respiratory system is essentially slower at defending itself against the oxidative stress fragrance creates. A fragrance exposure that someone with optimal GSTP1 activity clears without thinking becomes, for you, a source of prolonged irritation, tightness, and potentially asthmatic responses.

CYP1A2 is a phase I detoxification enzyme that sits in your liver and begins the process of breaking down fragrance chemicals into intermediate compounds. It’s the first step that makes these chemicals reactive enough for phase II enzymes to recognize and conjugate them. CYP1A2 is fast and powerful, and for most chemicals, that’s a good thing.

But here’s the paradox: depending on your CYP1A2 variant, you could have either reduced activity (slow metabolism) or increased activity (fast metabolism). If you’re a slow metabolizer, fragrance chemicals move slowly through phase I, creating a traffic jam. If you’re a fast metabolizer, you produce reactive intermediates very quickly, potentially overwhelming your phase II system. Either way, CYP1A2 variants can disrupt the balance of your detoxification pipeline. The system works best when phase I, phase II, and phase III are in harmony. Disruption at any point creates accumulation.

For fragrance sensitivity, reduced CYP1A2 activity is often more problematic. Fragrance molecules hang around longer, your cells stay exposed longer, and inflammation builds. You feel this as a slow, creeping sense of chemical burden rather than an immediate reaction.

MTHFR doesn’t directly metabolize fragrance chemicals, but it controls something equally important: the production of glutathione, which is essential to every detox enzyme on this list. MTHFR converts folate into the methylated form your body can use for the methylation cycle, which feeds into glutathione synthesis. If MTHFR is compromised, your glutathione levels drop, and suddenly every downstream detox pathway becomes less efficient.

The C677T variant, carried by roughly 40% of the population, reduces MTHFR enzyme activity by 40-70%. People with this variant produce significantly less glutathione, even if they’re eating a perfect diet and taking B vitamins. They’re attempting to power their detox system with a depleted fuel tank.

For fragrance sensitivity, the MTHFR connection is significant. You could have perfectly functioning GSTM1 and GSTP1 genes, but without enough glutathione to power them, they can’t do their job effectively. You feel chemically sensitive because your detox enzymes are literally running out of the substrate they need to work. It’s not that your genes are broken; it’s that the system is underfueled.

SOD2 is an enzyme that lives inside your mitochondria and does one specific, critical job: it neutralizes superoxide, a highly reactive free radical that forms whenever energy is being produced. When you inhale fragrance chemicals and your body tries to detoxify them, it generates a lot of oxidative stress. That stress is happening partly in your mitochondria. If SOD2 is compromised, those free radicals accumulate inside the energy powerhouses of your cells.

The Val16Ala variant is found in roughly 40% of the population (in homozygous form). This variant reduces SOD2 enzyme activity, meaning oxidative stress accumulates faster inside your mitochondria when you’re exposed to fragrance chemicals. Your cells experience accelerated mitochondrial damage from fragrance exposure, which triggers inflammatory pathways even faster. The result is that your body perceives fragrance chemicals as a bigger threat than it objectively is because the damage happening at the cellular level is happening more rapidly.

If you carry this variant and you’re sensitive to fragrances, you’re likely experiencing a double hit: fragrance chemicals aren’t clearing efficiently (phase I/II problems), and the oxidative stress they generate is accumulating faster (mitochondrial problem). You feel exhausted and inflamed after fragrance exposure.

NQO1 is a phase II detoxification enzyme that specializes in neutralizing quinones and other aromatic compounds, which are abundant in fragrance formulations. Many fragrance molecules, and the byproducts they create when your body tries to break them down, are either quinones themselves or generate quinones as intermediates. Without functional NQO1, your body struggles to detoxify these specific classes of chemicals.

The Pro187Ser variant, carried by roughly 4-20% of the population (depending on ancestry), can produce a complete loss of NQO1 function. If you have this variant, you lack the ability to neutralize a specific class of fragrance-derived chemicals that many people clear without even noticing. This creates a selective vulnerability. You might react to fragrances that others tolerate fine, and people might not understand why because they don’t have this genetic limitation.

For people with NQO1 loss-of-function variants, fragrance sensitivity is typically not a matter of being “too sensitive.” It’s a matter of lacking a specific enzymatic defense that most people take for granted. A fragrance that doesn’t bother others is genuinely harder for your body to clear.